| scholarly article | Q13442814 |
| P2093 | author name string | Thomas Gridley | |
| Lucy Liaw | |||
| Bahman Rostama | |||
| Calvin P H Vary | |||
| Christine R Norton | |||
| Jacqueline E Turner | |||
| Guy T Seavey | |||
| P2860 | cites work | BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. | Q36057921 |
| Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders | Q36079508 | ||
| Enhanced gene activation by Notch and BMP signaling cross-talk | Q36119543 | ||
| Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). | Q36140753 | ||
| BMP9 regulates endoglin-dependent chemokine responses in endothelial cells | Q36410172 | ||
| The role of extracellular matrix in vascular branching morphogenesis | Q36542074 | ||
| Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strength. | Q36750033 | ||
| Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. | Q37031726 | ||
| Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence | Q37080802 | ||
| Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells | Q37151702 | ||
| Therapeutic promise and challenges of targeting DLL4/NOTCH1. | Q38367121 | ||
| ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif | Q38855307 | ||
| Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling | Q39017680 | ||
| Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. | Q39320608 | ||
| Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion. | Q40256534 | ||
| Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. | Q40620265 | ||
| Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability | Q40876935 | ||
| A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis | Q42010099 | ||
| Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades | Q42098324 | ||
| Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level | Q42560909 | ||
| Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting | Q42876374 | ||
| Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration | Q44675917 | ||
| The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis | Q45345843 | ||
| Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1. | Q50596384 | ||
| Transforming growth factor-β-activated kinase 1 regulates angiogenesis via AMP-activated protein kinase-α1 and redox balance in endothelial cells. | Q50719379 | ||
| Chronic DLL4 blockade induces vascular neoplasms | Q59082154 | ||
| Laminin-Binding Integrins Induce Dll4 Expression and Notch Signaling in Endothelial Cells | Q61894113 | ||
| Bone morphogenetic protein-9 is a circulating vascular quiescence factor | Q24657942 | ||
| Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3 | Q24672178 | ||
| Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations | Q27302123 | ||
| Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer | Q28203143 | ||
| Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants | Q28505269 | ||
| Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors | Q28505707 | ||
| Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling | Q28587298 | ||
| Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization | Q28589223 | ||
| Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis | Q29614939 | ||
| Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds | Q30493655 | ||
| ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. | Q33719706 | ||
| Notch signaling regulates the lifespan of vascular endothelial cells via a p16-dependent pathway | Q33784355 | ||
| Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models | Q33818037 | ||
| Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors? | Q33957962 | ||
| ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth | Q34096297 | ||
| Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis | Q34141670 | ||
| PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization | Q34150579 | ||
| Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function | Q34458950 | ||
| Delta-like 4 induces notch signaling in macrophages: implications for inflammation | Q34632202 | ||
| Thrombospondins 1 and 2 function as inhibitors of angiogenesis | Q35114389 | ||
| Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression | Q35181476 | ||
| Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells | Q35584425 | ||
| Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model | Q35651465 | ||
| Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. | Q35842264 | ||
| Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. | Q35902676 | ||
| Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. | Q36018663 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2626-2637 | |
| P577 | publication date | 2015-10-15 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1. | |
| P478 | volume | 35 |
| Q47856805 | ALK1 signaling in development and disease: new paradigms. |
| Q28066886 | Activin receptor-like kinases: a diverse family playing an important role in cancer |
| Q47127514 | Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1. |
| Q98171203 | BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway |
| Q89637587 | BMP9 signaling promotes the normalization of tumor blood vessels |
| Q60932686 | Bone Morphogenetic Protein 9 Regulates Early Lymphatic-Specified Endothelial Cell Expansion during Mouse Embryonic Stem Cell Differentiation |
| Q38937592 | Delta-Like Ligand 4-Notch Signaling in Macrophage Activation |
| Q92732372 | Endothelial ERK1/2 signaling maintains integrity of the quiescent endothelium |
| Q92940369 | Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells |
| Q48647117 | FGF21 represses cerebrovascular aging via improving mitochondrial biogenesis and inhibiting p53 signaling pathway in an AMPK-dependent manner |
| Q35991193 | Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease |
| Q30362847 | Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice. |
| Q41108569 | Mechanisms of Smooth Muscle Cell Differentiation Are Distinctly Altered in Thoracic Aortic Aneurysms Associated with Bicuspid or Tricuspid Aortic Valves |
| Q58077846 | MicroRNA-30a as a candidate underlying sex-specific differences in neonatal hyperoxic lung injury: Implications for BPD |
| Q52353052 | NOTCH regulation of the endothelial cell phenotype. |
| Q91761126 | NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy |
| Q88938326 | Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation |
| Q52890704 | Self-Renewal and High Proliferative Colony Forming Capacity of Late-Outgrowth Endothelial Progenitors Is Regulated by Cyclin-Dependent Kinase Inhibitors Driven by Notch Signaling. |
| Q58750618 | The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer |
| Q91003142 | Translocating transcription factors in fluid shear stress-mediated vascular remodeling and disease |
| Q39403862 | Tumor angiogenesis and vascular normalization: alternative therapeutic targets |
| Q39393740 | Tumor angiogenesis revisited: Regulators and clinical implications. |
Search more.